CLINICAL_TRIALS
trial_result
· 2013-11-01
Clinical Trial Update: A Study in Healthy Subjects to Evaluate Bioavailability of 4 Formulations of E5501 [Phase 1]
Summary
Phase 1 study in healthy subjects evaluating the bioavailability of four formulations of E5501; the trial has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eisai Inc. | Conditions: Idiopathic Thrombocytopenic Purpura | Phase 1 | Status: COMPLETED